We sit down with you and build your perfect lead list. Book a call with founders.

Reticular Analysis

What is Reticular?

Reticular specializes in AI-driven solutions for drug discovery. Their unique approach utilizes curated knockout cohorts and extensive human datasets for target validation. This methodology accelerates drug development pipelines, enhancing confidence in research outcomes.

Location
San Francisco, United States
Employees
1-10
Founded
2024
Industry
AI/ML, Biotech, Data Analytics
Funding Category
Early Stage VC

Product Features & Capabilities

  • AI-curated knockout cohorts for target validation
  • Rich human datasets for accelerated drug discovery
  • Proprietary algorithms for data analysis
  • Comprehensive research support for biopharma
  • Customizable demo sessions for potential clients.

Other Considerations

Backed by angel investors from top biopharma and AI labs; Based in San Francisco and Boston; Notable focus on reducing risks in drug discovery.

Financial Overview

Pre-Seed
December 4, 2024
Investors: Y Combinator
Accelerator/Incubator
January 1, 2024
Investors: Not specified
Early Stage VC
June 1, 2025
Investors: Not specified
Want to research more data points on Reticular?
Start with Extruct